Altered expression of the L-arginine/nitric oxide pathway in ovarian cancer: metabolic biomarkers and biological implications.

MLA

Chen, Linfeng, et al. “Altered Expression of the L-Arginine/Nitric Oxide Pathway in Ovarian Cancer: Metabolic Biomarkers and Biological Implications.” BMC Cancer, vol. 23, no. 1, Sept. 2023, p. 844. EBSCOhost, https://doi.org/10.1186/s12885-023-11192-8.

APA

Chen, L., Tang, Q., Zhang, K., Huang, Q., Ding, Y., Jin, B., Liu, S., Hwa, K., Chou, C. J., Zhang, Y., Thyparambil, S., Liao, W., Han, Z., Mortensen, R., Schilling, J., Li, Z., Heaton, R., Tian, L., Cohen, H. J., … Ling, X. B. (2023). Altered expression of the L-arginine/nitric oxide pathway in ovarian cancer: metabolic biomarkers and biological implications. BMC Cancer, 23(1), 844. https://doi.org/10.1186/s12885-023-11192-8

Chicago

Chen, Linfeng, Qiming Tang, Keying Zhang, Qianyang Huang, Yun Ding, Bo Jin, Szumam Liu, et al. 2023. “Altered Expression of the L-Arginine/Nitric Oxide Pathway in Ovarian Cancer: Metabolic Biomarkers and Biological Implications.” BMC Cancer 23 (1): 844. doi:10.1186/s12885-023-11192-8.